Angiotensin-converting enzyme inhibitors in the treatment of sarcoidosis and association with ACE gene polymorphism: case series

Vinod Kaura; Neil V Kaura; Bobby N Kaura; Claire S Kaura

Angiotensin-converting enzyme inhibitors in the treatment of sarcoidosis and association with ACE gene polymorphism: case series

Indian J Chest Dis Allied Sci. 2013 Apr-Jun;55(2):105-7.

Authors

Vinod Kaura¹, Neil V Kaura, Bobby N Kaura, Claire S Kaura

Affiliation

¹ Department of Medicine, Community Hospital of San Bernardino, California 92411, USA. vkaura50@gmail.com

PMID: 24047001

Abstract

Angiotensin-converting enzyme (ACE) is used as a marker for sarcoid disease activity. We present an observational study of four African-American patients all of whom demonstrated improvement in their sarcoidosis after treatment with ACE inhibitors for hypertension.

Publication types

Case Reports

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Benzazepines / therapeutic use*
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Peptidyl-Dipeptidase A / genetics*
Polymorphism, Genetic
Sarcoidosis / drug therapy*
Sarcoidosis / enzymology
Sarcoidosis / genetics
Tomography, X-Ray Computed

Substances

Angiotensin-Converting Enzyme Inhibitors
Benzazepines
Peptidyl-Dipeptidase A
benazepril